CIK 0001832038 · <br>Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851403134
- Phone
- (781) 819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,089
- in 5 filings, $177K under 10b5-1 plans
Net −$177,089. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Andersen Jill −$53K Chief Legal Officer, Secretary sold 19% of stake
- Duke William E. −$32K Chief Financial Officer sold 19% of stake
- Green Julie −$32K Chief Human Resources Officer sold 19% of stake
- Lee Timothy Edward −$32K Chief Commercial Officer sold 19% of stake
- Allen Robert D. III −$29K Chief Scientific Officer sold 17% of stake
Reading 22 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-19 | MCGUIRE TERRANCE Director | Sale | −152,067 | $0.43 | $66K | 3,688,079 |
| 2024-12-18 | MCGUIRE TERRANCE Director | Sale | −74,764 | $0.47 | $35K | 3,840,146 |
| 2024-12-17 | MCGUIRE TERRANCE Director | Sale | −97,410 | $0.48 | $47K | 3,914,910 |
| 2024-12-16 | MCGUIRE TERRANCE Director | Sale | −65,359 | $0.47 | $31K | 4,012,320 |
| 2024-12-12 | MCGUIRE TERRANCE Director | Sale | −125,000 | $0.58 | $73K | 4,077,679 |
| 2024-12-11 | MCGUIRE TERRANCE Director | Sale | −160,400 | $0.59 | $95K | 4,202,679 |
| 2024-12-10 | MCGUIRE TERRANCE Director | Sale | −175,000 | $0.59 | $103K | 4,363,079 |
| 2024-12-09 | MCGUIRE TERRANCE Director | Sale | −150,000 | $0.61 | $92K | 4,538,079 |
| 2024-06-05 | Lee Timothy Edward Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2024-05-29 | MCGUIRE TERRANCE Director | Sale | −112,381 | $1.66 | $187K | 4,688,079 |
| 2024-05-21 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-21 | Cotter Sara Director | Grant or award · Stock Option (Right to Buy) | +41,369 | 41,369 | ||
| 2024-05-21 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-05-21 | Berry Tamsin Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-21 | Elia Marc Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-21 | Lindenboom Christine Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-21 | Gupta Srishti Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-01-24 | Green Julie Chief Human Resources Officer | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2024-01-19 | Adimab, LLC 10% owner | Sale | −5,000,000 | $3.95 | $19.8M | 21,687,906 |
| 2023-12-18 | Gowler Jeremy COO & CCO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 6 of 9 · 161 trades